Integrated Microfluidic Platform for Point-of-Care Serodiagnostics

用于护理点血清诊断的集成微流控平台

基本信息

  • 批准号:
    8393163
  • 负责人:
  • 金额:
    $ 30万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We aim to develop a fully integrated microfluidic immunodiagnostic platform utilizing a novel air-liquid cavity acoustic transducer (ALCAT) technology pioneered in the lab of Dr Abe Lee. The diagnosis platform is based on the well-established clinical diagnostic tool, the enzyme immunoassay (eg ELISA). ELISAs are an integral platform for clinical diagnosis because they are rapid, robust, and provide results that are highly sensitive and specific. Additionally, ELISAs rely on the inherent humoral immune response of the host to produce antibodies indicative of pathological status. In this proposal, we will form a strategic partnership of expertise in protein microarrays (Antigen Discovery, Inc. and Dr Phil Felgner) and in microfluidics (Dr Abe Lee) to develop a point-of-care diagnostic system consisting of a cost-effective disposable microfluidic plastic chip and a portable analyzer that can be driven by a mobile computing device for rapid serological evaluation of Melioidosis. By synergistically incorporating novel ALCAT-based approaches into these arrays we will have the versatility and power to reduce enzymatic development times, limit production costs, and fully integrate all components into a disposable assay. From previous NIH/NIAID funding we have discovered serodiagnostic antigens for 12 NIAID priority agents (Brucella melitensis, Francisella tularensis, Burkholderia pseudomallei, Coxiella burnetii, Salmonella enterica typhi, Rickettsia rickettsii, Orientia tsutsugamushi, Toxoplasma gondii, M. tuberculosis, variola major related pox viruses, Dengue, and West Nile). We have also identified serodiagnostic antigens for non-biodefense targets including: Bartonella henselae, Borrelia burgdorferi, Hepatitis B Virus, Chlamydia, Plasmodium falciparum, Human papillomavirus, and Herpes simplex virus. This approach will leverage our existing content of serodiagnostic antigens (and appropriate banked sera collection) to produce a multiplex device that will contain multiple antigens from numerous pathogens and enable clinicians to determine which pathogen an individual was exposed to. We believe the platform takes advantage of this wealth of content, and marries it to a versatile ALCAT-based microfluidics approach to produce a true lab-on-a- chip tool that is equipment free, technical expertise unrestricted, and useful for both developed and undeveloped countries. This approach produces a an immensely powerful diagnostic platform that will compliment current assays, provide diagnosis for a broad range of diseases, and is capable of utilizing additional enzyme immunoassay-based content. This proposal is an effective integration of emerging microarray technologies and will set the stage for future serological detection systems. PUBLIC HEALTH RELEVANCE: Centralized testing in well-resourced reference laboratories cannot adequately address the unpredictable demand for rapid diagnostics during mass disasters, natural disease outbreaks, and bioterrorist threats. During such emergencies, first responders must rely on accurate diagnostics that are quickly and efficiently deployable to patients who may not have easily recognizable signs or symptoms of an infection. Point-of-care (POC) multiplex diagnostics are well-suited to fill this important role as they are highly portable do not require extensive training, and provide prompt sample-to-answer times.
描述(由申请人提供):我们的目标是开发一个完全集成的微流控免疫诊断平台,利用由Abe Lee博士的实验室首创的新型气液腔声换能器(ALCAT)技术。该诊断平台是基于成熟的临床诊断工具--酶免疫分析(如酶联免疫吸附试验)。ELISA是临床诊断的一个不可或缺的平台,因为它们快速、可靠,并提供高度敏感和特异的结果。此外,ELISA依赖于宿主固有的体液免疫反应来产生指示病理状态的抗体。在这项提议中,我们将结成蛋白质微阵列(Antigen Discovery,Inc.和Phil Felgner博士)和微流控(Abe Lee博士)专业知识的战略合作伙伴关系,以开发一种由成本效益高的一次性微流控塑料芯片和便携式分析仪组成的护理点诊断系统,该分析仪可以由移动计算设备驱动,用于对类梅毒进行快速血清学评估。通过将基于ALCAT的新方法协同整合到这些阵列中,我们将拥有减少酶开发时间、限制生产成本并将所有成分完全集成到一次性检测中的多功能性和能力。从NIH/NIAID以往的资助中,我们已经发现了12种NIAID优先病原体(布鲁氏菌、图拉氏菌、假鼻疽伯克霍尔德氏菌、柯克斯体、伤寒沙门氏菌、立克次体、东方体、弓形虫、结核分枝杆菌、与天花相关的主要痘病毒、登革热和西尼罗河)的血清诊断抗原。我们还鉴定了非生物防御靶标的血清诊断抗原,包括:亨氏巴尔通体、伯氏疏螺旋体、乙肝病毒、衣原体、恶性疟原虫、人乳头瘤病毒和单纯疱疹病毒。这种方法将利用我们现有的血清诊断抗原内容(和适当的银行血清收集)来生产一种多路设备,该设备将包含来自多种病原体的多种抗原,并使临床医生能够确定个人接触了哪种病原体。我们相信,该平台利用了这些丰富的内容,并将其与基于ALCAT的多功能微流体方法相结合,以生产真正的芯片实验室工具,该工具无需设备,技术专业知识不受限制,对发达国家和欠发达国家都有用。这种方法产生了一个非常强大的诊断平台,将补充现有的分析,提供对广泛的疾病的诊断,并能够利用额外的基于酶免疫分析的内容。这项提议是对新兴微阵列技术的有效整合,并将为未来的血清学检测系统奠定基础。 公共卫生相关性:在资源充足的参考实验室进行集中检测,不能充分满足在大规模灾难、自然疾病暴发和生物恐怖威胁期间对快速诊断的不可预测的需求。在这种紧急情况下,急救人员必须依靠准确的诊断,这些诊断可以快速有效地应用于那些可能没有容易识别的感染迹象或症状的患者。护理点(POC)多路诊断非常适合担任这一重要角色,因为它们高度便携,不需要广泛的培训,并提供快速的样本到答案时间。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Abraham P. Lee其他文献

A Microphysiological HHT-on-a-Chip Platform Recapitulates Patient Vascular Lesions
微生理 HHT 芯片平台重现患者血管病变
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Christopher C W Hughes;Jennifer Fang;Christopher J. Hatch;Jillian W. Andrejecsk;William Van Trigt;Damie J Juat;Yu;Satomi Matsumoto;Abraham P. Lee
  • 通讯作者:
    Abraham P. Lee
Advanced Imaging Catheter: Final Project Report
高级成像导管:最终项目报告
  • DOI:
    10.2172/15005329
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    P. Krulevitch;B. Colston;L. DaSilva;D. Hilken;J. Kluiwstra;Abraham P. Lee;R. London;R. Miles;Daniel L. Schumann;K. Seward;Amy W. Wang
  • 通讯作者:
    Amy W. Wang
Mixed-sputter deposition of Ni-Ti-Cu shape memory films
Ni-Ti-Cu形状记忆薄膜的混合溅射沉积
  • DOI:
    10.1016/0040-6090(95)07072-9
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    P. Krulevitch;P. Ramsey;D. Makowiecki;Abraham P. Lee;M. A. Northrup;G. Johnson
  • 通讯作者:
    G. Johnson
A Microdevice To Indicate Human Neural Stem Cell Differentiation Potential
  • DOI:
    10.1016/j.bpj.2008.12.169
  • 发表时间:
    2009-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Fatima H. Labeed;Jente Lu;Steve A. Marchenko;Kai F. Hoettges;Michael P. Hughes;Edwin S. Monuki;Abraham P. Lee;Lisa A. Flanagan
  • 通讯作者:
    Lisa A. Flanagan
DORA: A Dynamic File Assignment Strategy with Replication
DORA:具有复制功能的动态文件分配策略

Abraham P. Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Abraham P. Lee', 18)}}的其他基金

Acoustic microvortices instrumentation for dosage controlled, high efficiency cell engineering
用于剂量控制、高效细胞工程的声学微涡流仪器
  • 批准号:
    10629435
  • 财政年份:
    2022
  • 资助金额:
    $ 30万
  • 项目类别:
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics
用于护理点血清诊断的集成微流控平台
  • 批准号:
    8513911
  • 财政年份:
    2012
  • 资助金额:
    $ 30万
  • 项目类别:
Microfluidics systems for formulation of contrast agents for molecular imaging
用于配制分子成像造影剂的微流体系统
  • 批准号:
    7342404
  • 财政年份:
    2007
  • 资助金额:
    $ 30万
  • 项目类别:
Microfluidics systems for formulation of contrast agents for molecular imaging
用于配制分子成像造影剂的微流体系统
  • 批准号:
    7186482
  • 财政年份:
    2007
  • 资助金额:
    $ 30万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了